Diagnostics for the Real World
PrivateLast Round
Grant
Apr 2, 2020
Total Funding Raised
$12.77M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Diagnostics for the Real World operates in Healthcare & Life Sciences and is based in Morgan Hill, California. Its latest recorded funding round was a Grant round in April 2020.
Diagnostics for the Real World is a medical device company that develops and manufactures a point-of-care molecular diagnostics platform for the simple and accurate detection of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diagnostics for the Real World Comparables
Compare Diagnostics for the Real World with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Molbio Diagnostics | 79% | |
| binx health | 77% | |
| Abbott Laboratories | 74% |
For institutional investors. Book with your work email.
Diagnostics for the Real World Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 2, 2020 | ||||
| Seed | Dec 18, 2003 |
For institutional investors. Book with your work email.
Diagnostics for the Real World Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Children's Investment Fund Foundation | Grant |
| Cambridge Enterprise | Grant |
| Unitaid | Grant |
| Wellcome Trust | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 270% MoM, reaching 4.7K.
- Apr 2, 2020
$3M raised from Cambridge Enterprise Seed Funds.
For institutional investors. Book with your work email.
Diagnostics for the Real World Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Diagnostics for the Real World's valuation, stock price, and market status.
Is Diagnostics for the Real World a public or private company?
Diagnostics for the Real World is a private company.
What is the current stock price of Diagnostics for the Real World?
Diagnostics for the Real World is a private company, so its shares have no public market price. Caplight tracks Diagnostics for the Real World's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Diagnostics for the Real World worth (valuation)?
Valuation information for Diagnostics for the Real World is not publicly available.
Can I buy Diagnostics for the Real World stock?
Diagnostics for the Real World shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Diagnostics for the Real World's last funding round?
Diagnostics for the Real World's most recent funding round was Grant on April 2, 2020.
Who are the main investors in Diagnostics for the Real World?
Key investors in Diagnostics for the Real World include Unitaid.
Will Diagnostics for the Real World IPO soon?
No public IPO plans have been announced for Diagnostics for the Real World.
How can I track Diagnostics for the Real World secondary market activity?
Caplight tracks bids, offers, and trades in Diagnostics for the Real World's shares on secondary markets.